4
Changes in Ownership
Raphael Pharmaceutical Inc. Filed Acc 0001213900-24-025519
Chief Technology Officer acquired 999,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Louria Hayon Igal Chief Technology Officer | 2023-08-29 | Option exercise | +999,000 | $0.01 | $9,990 | 999,000 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Louria Hayon Igal Chief Technology Officer | 2023-08-29 | Option exercise · Warrants to purchase Common Stock | −999,000 | 0 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…